With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – Contralateral prophylactic mastectomy slightly improves breast cancer-specific survival, primarily in young women with early-stage estrogen receptor (ER)-negative disease, new research shows. “The efficacy…
NEW YORK (Reuters Health) – Pregnant women who’ve had abnormal cervical tissue removed with a loop electrosurgical procedure (LEEP) are not at increased risk for preterm delivery, a…
NEW YORK (Reuters Health) – In postmenopausal women with osteoporosis, the selective estrogen-receptor modulator lasofoxifene cuts the risks of fractures, estrogen-receptor-positive breast cancer, coronary disease, and stroke, the…
NEW YORK (Reuters Health) – Intra-partum nevirapine, given to prevent HIV transmission, contributes to HIV resistance mutations to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) – but a one-month postpartum course…
NEW YORK (Reuters Health) – Three weeks of hypofractionated whole-breast radiotherapy is at least as good as 5 weeks of standard radiotherapy after breast-conserving surgery for invasive cancer,…
NEW YORK (Reuters Health) – Use of paroxetine during tamoxifen therapy reduces the breast cancer survival benefit by 25% or more depending on the amount of time the…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – In women over 55, simple ovarian cysts are common, usually resolving or persisting without progression, according to data from the prospective Prostate, Lung,…
NEW YORK (Reuters Health) – Adding trastuzumab (Herceptin) to standard chemotherapy can significantly improve event-free survival in women with HER2-positive locally advanced or inflammatory breast cancer, according to…
NEW YORK (Reuters Health) – It makes no difference whether internal tocodynamometry or external monitoring is used during induced or augmented labor – either way, the rate of…
